Drug development for most important tropical parasitic diseases, such as lymphatic filariasis, has been orphaned by pharmaceutical companies as not having enough profit potential. However, when the choice of a novel molecular target for infectious diseases therapeutics is shared between an academic parasitology research team and a pharmaceutical company research group, this provides a unique opportunity for nucleation of a collaborative anti-parasite drug discovery partnership. The long-term goal of this research program is the pre-clinical development of therapeutic AARS enzyme inhibitors to eradicate the nematode parasites that cause human filariasis. Filariasis is one of the top ten tropical parasitic diseases ranked by the World Health Organization (WHO), yet the drug of choice to treat this disease does not kill adult worms, and concerns for drug resistance are rising because of wide spread use of the same drugs in community-based human control programs and veterinary medicine. The enzymes targeted by this new research program include both the unique AARS expressed in filarial parasites and those within the Wolbachia endosymbiotic bacteria that are essential for worm viability. ? ? Our approach couples high throughput screening of proprietary chemical and natural product libraries using 1) recombinant filarial and Wolbachia MRS and 2) protein structure-based drug design techniques. Screening costs are minimized by the use of SLIDE (Screening for Ligands with Induced Fit Docking) protein structure based design software developed at MSU. Atomic structures of inhibitor:enzyme complexes are solved crystallographically, serving as templates for ligand searches, lead compound optimization, and validation by in vitro parasite killing assays. Novel enzyme inhibitors with the best pharmacological properties are selected for large-scale organic synthesis and future clinical phase studies. AARS are a critically important family of structurally heterogeneous enzymes that can be identified using a combination of molecular and bioinformatic techniques. The interdisciplinary partnership established by this program provides an infrastructure and model for future infectious disease therapeutics research to combat the full spectrum of bacterial, fungal, unicellular, and multicellular parasites of man, as well as insect vectors of human disease. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI053877-02
Application #
6665259
Study Section
Special Emphasis Panel (ZAI1-ALR-M (S1))
Program Officer
Coyne, Philip Edward
Project Start
2002-09-30
Project End
2007-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2003
Total Cost
$584,230
Indirect Cost
Name
Michigan State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Rateb, Mostafa E; Yang, Dong; Vodanovic-Jankovic, Sanja et al. (2015) Adipostatins A-D from Streptomyces sp. 4875 inhibiting Brugia malayi asparaginyl-tRNA synthetase and killing adult Brugia malayi parasites. J Antibiot (Tokyo) 68:540-2
Rateb, Mostafa E; Yu, Zhiguo; Yan, Yijun et al. (2014) Medium optimization of Streptomyces sp. 17944 for tirandamycin B production and isolation and structural elucidation of tirandamycins H, I and J. J Antibiot (Tokyo) 67:127-32
Kron, Michael A; Metwali, Ahmed; Vodanovic-Jankovic, Sanja et al. (2013) Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis. Clin Vaccine Immunol 20:276-81
Artero, Jean Baptiste; Teixeira, Susana C M; Mitchell, Edward P et al. (2010) Crystallization and preliminary X-ray diffraction analysis of human cytosolic seryl-tRNA synthetase. Acta Crystallogr Sect F Struct Biol Cryst Commun 66:1521-4
Zavodszky, Maria I; Rohatgi, Anjali; Van Voorst, Jeffrey R et al. (2009) Scoring ligand similarity in structure-based virtual screening. J Mol Recognit 22:280-92
Keating, Kevin S; Flores, Samuel C; Gerstein, Mark B et al. (2009) StoneHinge: hinge prediction by network analysis of individual protein structures. Protein Sci 18:359-71
Cozzini, Pietro; Kellogg, Glen E; Spyrakis, Francesca et al. (2008) Target flexibility: an emerging consideration in drug discovery and design. J Med Chem 51:6237-55
Tuinstra, Robbyn L; Peterson, Francis C; Kutlesa, Snjezana et al. (2008) Interconversion between two unrelated protein folds in the lymphotactin native state. Proc Natl Acad Sci U S A 105:5057-62
Kron, Michael; Leykam, Joseph; Kopaczewski, Jessica et al. (2007) Identification of diadenosine triphosphate in Brugia malayi by reverse phase high performance liquid chromatography and MALDI mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 856:234-8
Crepin, Thibaut; Yaremchuk, Anna; Tukalo, Mikhail et al. (2006) Structures of two bacterial prolyl-tRNA synthetases with and without a cis-editing domain. Structure 14:1511-25

Showing the most recent 10 out of 17 publications